Bill Bertrand

(Mr. William Bertrand Jr., Esq., J.D.)

Currently holds positions in Adaptimmune Therapeutics PLC, Medimmune LLC and Ardelyx Inc

Positions

Position Company Period
Chief Operating Officer Adaptimmune Therapeutics PLC March 15, 2017 -
Executive Vice President, General Counsel Medimmune LLC None -
Independent Director Ardelyx Inc Oct. 26, 2015 -
Executive Vice President, General Counsel Infinity Pharmaceuticals Inc Oct. 19, 2015 - Sept. 2, 2016
Acting Chief Operating Officer Salix Pharmaceuticals Ltd Jan. 30, 2015 - April 1, 2015
Bill Bertrand's trades of Adaptimmune Therapeutics PLC's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-17 2025-01-17
S Sale
5,584 -42.6%
0.58
USD 3,243 		5,584 -42.6% 0.58 USD 3,243
2025-01-15 2025-01-15
S Sale
9,803 -41.6%
0.57
USD 5,635 		9,803 -41.6% 0.57 USD 5,635
2025-01-15 2025-01-13
S Sale
5,471 -41.8%
0.59
USD 3,216 		5,471 -41.8% 0.59 USD 3,216
2025-01-15 2025-01-13
S Sale
4,268 -42.2%
0.59
USD 2,509 		4,268 -42.2% 0.59 USD 2,509
2024-01-17 2024-01-17
S Sale
13,599 -40.2%
0.67
USD 9,152 		13,599 -40.2% 0.67 USD 9,152
2024-01-17 2024-01-17
S Sale
5,309 -40.5%
0.67
USD 3,573 		5,309 -40.5% 0.67 USD 3,573
2024-01-17 2024-01-16
S Sale
4,681 -40.0%
0.79
USD 3,698 		4,681 -40.0% 0.79 USD 3,698
2024-01-12 2024-01-12
S Sale
5,220 -39.9%
0.85
USD 4,458 		5,220 -39.9% 0.85 USD 4,458
2024-01-12 2024-01-11
S Sale
4,009 -39.6%
0.84
USD 3,354 		4,009 -39.6% 0.84 USD 3,354
2023-01-17 2023-01-17
S Sale
4,440 -37.9%
1.86
USD 8,250 		4,440 -37.9% 1.86 USD 8,250
2023-01-12 2023-01-12
S Sale
4,973 -38.0%
1.71
USD 8,484 		4,973 -38.0% 1.71 USD 8,484
2023-01-12 2023-01-11
S Sale
3,843 -38.0%
1.75
USD 6,713 		3,843 -38.0% 1.75 USD 6,713
2023-01-04 2023-01-04
S Sale
3,584 -38.3%
1.69
USD 6,071 		3,584 -38.3% 1.69 USD 6,071
2022-01-18 2022-01-18
S Sale
4,368 -37.3%
3.19
USD 13,942 		4,368 -37.3% 3.19 USD 13,942
2022-01-13 2022-01-12
S Sale
2,248 -37.5%
3.54
USD 7,967 		2,248 -37.5% 3.54 USD 7,967
2022-01-13 2022-01-11
S Sale
3,770 -37.3%
3.56
USD 13,409 		3,770 -37.3% 3.56 USD 13,409
2022-01-05 2022-01-04
S Sale
3,490 -37.3%
4.06
USD 14,184 		3,490 -37.3% 4.06 USD 14,184
2021-01-12 2021-01-12
S Sale
2,234 -37.2%
6.15
USD 13,744 		2,234 -37.2% 6.15 USD 13,744
2021-01-05 2021-01-04
S Sale
3,499 -37.4%
5.33
USD 18,642 		3,499 -37.4% 5.33 USD 18,642
2020-12-15 2020-12-14
B Purchase
207,000 +266.0%
0.69
USD 143,824 		207,000 +266.0% 0.69 USD 143,824
2020-01-15 2020-01-14
S Sale
2,397 -39.9%
5.13
USD 12,308 		2,397 -39.9% 5.13 USD 12,308
2020-01-07 2020-01-06
S Sale
3,731 -39.8%
1.20
USD 4,477 		3,731 -39.8% 1.20 USD 4,477
2019-01-16 2019-01-14
S Sale
2,271 -37.8%
5.37
USD 12,194 		2,271 -37.8% 5.37 USD 12,194
// ... existing code ... // ... rest of the file ...